Effectiveness of Care Management in Alzheimer Patients
AIDALZ
Evaluation de la Mise en Place d'un Auxiliaire d'évaluation Dans la Prise en Charge de la Maladie d'Alzheimer et Des Maladies apparentées en France
1 other identifier
interventional
270
1 country
1
Brief Summary
Context: The French Alzheimer plan 2008-2012 includes the implementation of "disease managers" or social workers, from the onset of the disease, for every patient with a diagnosis of Alzheimer disease or associated disorder. However, previous trials evaluating the efficacy of a systematic intervention for each case from the onset of the disease, including non complex cases, have shown little evidence. Objective: To evaluate the efficacy of a social worker to prevent behavioural problem for patient with a new diagnosis of Alzheimer disease or associated disorder. Design and setting: Multicentric cluster randomized control trial. Patients from several memory consultations and specialists (neurologist, psychiatrist or geriatrician) in France are included. Intervention: In addition to usual care, patients in the intervention group have systematic home visits from a social worker and regular follow-ups by phone over a one-year period. This social worker informs the patient and caregiver, evaluates the needs, gives advices to prevent complications and is a link between the patient and the memory consultation or the specialist. Patient in the control group have absolutely no intervention and are followed-up as usually. In order to not modify the usual care, they have no information on their participation in this trial before the one-year evaluation. Main outcome measure: NeuroPsychiatric Inventory (NPI) administrated at one year, which evaluates frequency, severity and repercussion of several behavioural problems. Secondary outcomes included disability, cognition, depression, health, quality of life, institutionalization, and resource use.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2009
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 24, 2009
CompletedFirst Submitted
Initial submission to the registry
March 4, 2010
CompletedFirst Posted
Study publicly available on registry
March 5, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 2, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
October 2, 2013
CompletedAugust 28, 2017
August 1, 2017
3.9 years
March 4, 2010
August 25, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
NeuroPsychiatric Inventory (NPI)
Evaluation of frequency, severity and repercussion of several behavioural problems
1 year
Secondary Outcomes (12)
Cohen-Mansfield Agitation Inventory (CMAI)
1 year
Apathy Inventory
1 year
Disablement Assessment for Dementia (DAD)
1 year
Mini Mental State Examination (MMSE)
1 year
Global Deterioration Scale (GDS)
1 year
- +7 more secondary outcomes
Study Arms (2)
Social worker
EXPERIMENTALControl
NO INTERVENTIONControl group is followed-up as usually (usual care)
Interventions
Systematic home visits and regular follow-ups by phone from a social worker
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of Alzheimer's Disease or other dementia (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition \[DSM IV\] criteria of dementia)
- Presence of an informal caregiver
- Mild to moderately severe dementia (MMSE \[10-28\])
- Diagnosis of dementia made by a specialist ≤ 6 months
- Patient affiliated to the national health insurance system
You may not qualify if:
- Institutionalized patient
- Patient on legal guardianship
- Behavioural problem with important clinical repercussion
- Psychotic syndrome
- Severe and unstable general pathology
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
ISPED (Institut de Santé Publique, d'Epidémiologie et de Développement)
Bordeaux, 33076, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 4, 2010
First Posted
March 5, 2010
Study Start
November 24, 2009
Primary Completion
October 2, 2013
Study Completion
October 2, 2013
Last Updated
August 28, 2017
Record last verified: 2017-08